Register Here
PRN Meeting: October 22, 2024 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).
Target Audience:
Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.
Course Director: James F. Braun, DO, President & Program Planner, Physicians' Research Network
Moderator: Kathryn Anastos, MD, Professor of Medicine, Epidemiology and Population Health; Albert Einstein College of Medicine and Montefiore Medical Center
Guest Speakers and Presentations:
New Drugs for HIV Treatment and Prevention
Roy M. Gulick, MD, MPH
Rochelle Belfer Professor in Medicine
Chief, Division of Infectious Diseases
Weill Cornell Medicine/New York Presbyterian Hospital
New York, NY
Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the ACTG and the HIV Prevention Trials Network (HPTN), sponsored by the NIH.
At the completion of this educational activity learners will:
1. Learn about new formulations of existing antiretroviral drugs.
2. Learn about investigational drugs in existing antiretroviral drug classes.
3. Learn about investigational drugs with new mechanisms of action.
Developing Sex & Gender-tailored Strategies for Healthy Aging with HIV: The Effect of Low-level Viremia and Non-AIDS Comorbidity
Lauren F. Collins, MD, MSc
Assistant Professor, Division of Infectious Diseases
Emory University School of Medicine
Atlanta, GA
Dr. Lauren Collins (MD, MSc) is an Assistant Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine. She attends on the inpatient ID/HIV services at Grady Memorial Hospital and is a primary care physician at the Grady Ponce de Leon Center in the Adult and Women’s clinics. Since 2021, she has served as the Medical Director of the Grady Ponce Long-acting Antiretroviral Therapy Program. Dr. Collins’s clinical and research interests focus on improving the care and outcomes of persons with HIV across the lifespan, and in particular, women and those affected by the Southern HIV/AIDS epidemic. Her NIH K23 Award is focused on developing novel tools and strategies for aging-related multimorbidity screening and prevention in persons with HIV that are sex and gender tailored. She also leads a CDC U01 award that uses mixed methods to assess facilitators, barriers, and preferences for long-acting antiretroviral therapy use in cis-gender Black women with HIV in the South with the goal of promoting patient-centered and equitable scale-up of HIV treatment innovation.
At the completion of this educational activity learners will:
1. Be able to describe the burden of non-AIDS comorbidities across the adult lifespan of persons with HIV with an emphasis on sex and gender differences including women’s health transitions.
2. Be able to evaluate sex and gender-specific and HIV-related factors contributing to comorbidity burden and implications for refined multimorbidity screening and prevention in this population.
3. Understand the prevalence and impact of low-level viremia in men and women living with HIV on virologic failure and multimorbidity.
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.
The Medical Society of the State of New York designates this live activity for a maximum 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosure Statements:
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Program Planner) has no relevant financial relationships to disclose.
- Dr. Kathryn Anastos, MD (Moderator) TBA.
- Dr. Roy M. Gulick, MD, MPH (Presenter) has no relevant financial relationships to disclose. Dr. Gulick will submit his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
- Dr. Lauren F. Collins, MD, MSc (Presenter) has no relevant financial relationships to disclose. Dr. Collins will submit her slides in advance for adequate peer review and will support her presentation and clinical recommendations with the best available evidence from the medical literature.
Financial Support:
This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare and by a generous charitable contribution from Northwell Health Center for AIDS Research & Treatment.